Showing results (291-300 of 316) with videos related to
Sort By:
Pageof 32
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.Cell Stem Cell|January 10, 2015
Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategiesMarli Silva, Laurence Daheron, Hannah Hurley, et al.Nature Medicine|January 19, 2024
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoringHani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.Trials|November 8, 2018
DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.Health Technology Assessment (Winchester, England)|October 30, 2019
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshopJonathan A Cook, Steven A Julious, William Sones, et al.Nature Genetics|July 3, 2025
Detecting and quantifying clonal selection in somatic stem cellsVerena Körber, Niels Asger Jakobsen, Naser Ansari-Pour, et al.Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.Stem Cells Translational Medicine|February 5, 2015
Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standardsAnna French, Christopher Bravery, James Smith, et al.Pageof 32